Bulk Drug Park Proposed

A webinar on Stakeholder consultation for the proposed Bulk Drug Park in Himachal Pradesh was organised on October 29, 2020, at 03.30 PM under the chairmanship of Hon’ble Chief Minister of Himachal Pradesh.

Key highlights of webinar on Bulk drug:

Shri B R Sikri, Vice President, Bulk Drug Manufacturers Association

“The entire world is looking at India as a global pharma manufacturing hub and shared the benefits accruing from Production Linked Incentives (PLI) Schemes of the Government of India for the pharma sector”

Shri Pankaj Patel, Chairman & MD, Zydus Cadila

“Power is the biggest USP of the State for the API industry and the State should keep the tariff most competitive”

Shri Deepak Sapra, CEO, Global API Business, Dr. Reddy's Laboratories

“R&D is one of the key elements for growth in the API industry and R&D acts as a main infrastructure pillar for the Pharma Industry”

Shri B R Sikri, Vice President, Bulk Drug Manufacturers Association

“The entire world is looking at India as a global pharma manufacturing hub and shared the benefits accruing from Production Linked Incentives (PLI) Schemes of the Government of India for the pharma sector”

Shri Anil Kumar Jain, CEO, Global API Business, Sun Pharma

“Competitive advantage over other states in Bulk Drug Park, the focus should be kept on minimising the cost of production.”

Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs

“API products should be cost effective and robust infrastructure plays an important role in making API a global industry. API industry will require appropriate talent, good policies, a safer environment and an enabling ecosystem that includes stay and work facilities in the proposed Bulk Drug park.”

Shri Kuber Jagdale, API Head, Cipla

“The critical components in API manufacturing are technology and skilled manpower thereby there is a requisite of skilled and technical manpower. The State Government should create a strong Industry- Academic linkage and should obtain environment clearance for the entire bulk drug park thereby helping the API units and making a fast-forward progress.”

Shri Jayant Dwivedy, Executive Director, USV Limited

“To build a strong ecosystem for the Bulk Drug Industry, emphasis should be laid on robust R&D facilities, industrial infrastructure and efficient connectivity.”